<?xml version="1.0" encoding="UTF-8"?>
<results title="compound">
 <result pre="and minor components (&amp;lt; 6%) such as linalool (3.9%), cinamyl" exact="acetate" post="(3.8%), α-caryophyllene (5.3%) and limonene (2%). Complete inhibition of"/>
 <result pre="trans-cinnamaldehyde, and minor components such as eugenyl acetate, linalool, and" exact="benzyl" post="benzoate, each having antifungal activity [ 16– 20]. CNB"/>
 <result pre="GC–MS) were E-cinnamaldehyde (74%), α-caryophyllene (5.3%), linalool (3.9%) and E-cinnamyl" exact="acetate" post="(3.8%). Minor components with known function included limonene (2%),"/>
 <result pre="(3.8%). Minor components with known function included limonene (2%), eugenyl" exact="acetate" post="(0.6%), α-pinene (0.3%) and benzyl benzoate (0.6%). Another minor"/>
 <result pre="function included limonene (2%), eugenyl acetate (0.6%), α-pinene (0.3%) and" exact="benzyl" post="benzoate (0.6%). Another minor constituent was p-cymene (1.4%). RSY150"/>
 <result pre="and anaphase arrest. Minor components, which include limonene (2%), eugenyl" exact="acetate" post="(0.6%), linalool (3.9%) and benzyl benzoate (0.6%), also contribute"/>
 <result pre="which include limonene (2%), eugenyl acetate (0.6%), linalool (3.9%) and" exact="benzyl" post="benzoate (0.6%), also contribute to CNB oil antifungal activity."/>
 <result pre="tube formation and alters cell membrane integrity [ 92]. Eugenyl" exact="acetate" post="and linalool exhibit anti-virulence activity by inhibiting germ tube"/>
 <result pre="Hmoteh J Thamjarungwong B Voravuthikunchai SP Antifungal potential of eugenyl" exact="acetate" post="against clinical isolates of Candida species Microb Pathog 2016"/>
</results>
